Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Paradoxical Findings in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors: Suboptimal Disease Control Perceived As Satisfactory

Anna Gaya, Luis Fernando Fernández Fuertes, Mónica Ballesteros Andrés, Silvia De La Iglesia Íñigo, Rafael Andrés Del Orbe Barreto, Fernando Fernández Fuertes, Ana Pilar Gonzalez, Isidro Jarque, Esperanza Lavilla, Ramiro Nuñez Vasquez, Eduardo José Salido, Maria Vahí, Carlos Vallejo

Blood (2023) 142 (Supplement 1): 5645.

https://doi.org/10.1182/blood-2023-185939

Published: 2023

Journal Articles

Biomarker Analyses in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Crovalimab and Eculizumab: Results from the Phase III Randomized COMMODORE 2 Trial

Pontus Lundberg, Silvia de la Iglesia, Richard J Kelly, Austin Kulasekararaj, Jun-Ichi Nishimura, Antonio M Risitano, Alexander Roeth, Simon Buatois, Sammy Chebon, Himika Patel, Anna Kiialainen

Blood (2023) 142 (Supplement 1): 4088.

https://doi.org/10.1182/blood-2023-178694

Published: 2023

Journal Articles

Management of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) - Data from the Spanish PNH Registry

Silvia De La Iglesia Iñigo, MD PhD, Cristina Notario McDonell, MD, Anna Gaya Valls, María Teresa Cedena Romero, MD PhD, María Isabel Gómez Roncero, MD, Beatriz Arrizabalaga Amunchastegui, MD PhD, Carmen Monteserin Monteserin, MD, Esperanza Lavilla Rubira, MD PhD, Ana María Villegas Martínez, Prof.

Blood (2016) 128 (22): 4811.

https://doi.org/10.1182/blood.V128.22.4811.4811

Published: 2016

Journal Articles

Serum Fructosamine As an Alternative to Glycated Hemoglobin (HbA1c) for Glycemic Assessment in Diabetic Patients with Hemoglobin (Hb) Louisville

Mercedes Lorenzo-Medina, PhD, Silvia De-La-Iglesia, PhD, Lucia Quintana-Hidalgo, MD, Lidia Ruiz-Garcia, MD, Ruth Martin-Alfaro, MD, Juan Herrada, MD

Blood (2012) 120 (21): 4771.

https://doi.org/10.1182/blood.V120.21.4771.4771

Published: 2012

Journal Articles

A Predictive Statistical Model To Identify Thalassemic Phenotype (β 0 vs β + ) in Heterozygous β-Thalassemia.

Jose Manuel Calvo-Villas, MD, Paloma Ropero, MD, Silvia De la Iglesia, MD, Maria Francisca Zapata, MD, Alejandro Mayosky, MD, Francisco Sicilia, MD

Blood (2007) 110 (11): 3823.

https://doi.org/10.1182/blood.V110.11.3823.3823

Published: 2007

Journal Articles

Serum Soluble Transferrin Receptor in Heterozygous β-Thalassaemia: Application in the Diagnosis of Iron Deficiency and as Hematologic Marker of Erythroid Activity According to Thalassaemic Genotypes (β 0 vs β + ).

Jose Manuel Calvo-Villas, MD, María Francisca Zapata, MD, Ivan Alvarez, MD, Silvia de la Iglesia, MD, Jorge Cuesta, MD, Elena Carreter, MD, Francisco Sicilia, MD

Blood (2006) 108 (11): 3828.

https://doi.org/10.1182/blood.V108.11.3828.3828

Published: 2006

NARROW

Paradoxical Findings in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors: Suboptimal Disease Control Perceived As Satisfactory

Biomarker Analyses in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Crovalimab and Eculizumab: Results from the Phase III Randomized COMMODORE 2 Trial

Management of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) - Data from the Spanish PNH Registry

Serum Fructosamine As an Alternative to Glycated Hemoglobin (HbA1c) for Glycemic Assessment in Diabetic Patients with Hemoglobin (Hb) Louisville

A Predictive Statistical Model To Identify Thalassemic Phenotype (β 0 vs β + ) in Heterozygous β-Thalassemia.

Serum Soluble Transferrin Receptor in Heterozygous β-Thalassaemia: Application in the Diagnosis of Iron Deficiency and as Hematologic Marker of Erythroid Activity According to Thalassaemic Genotypes (β 0 vs β + ).

Email alerts

ASH Publications

American Society of Hematology

Paradoxical Findings in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors: Suboptimal Disease Control Perceived As Satisfactory

Biomarker Analyses in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Crovalimab and Eculizumab: Results from the Phase III Randomized COMMODORE 2 Trial

Management of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) - Data from the Spanish PNH Registry

Serum Fructosamine As an Alternative to Glycated Hemoglobin (HbA1c) for Glycemic Assessment in Diabetic Patients with Hemoglobin (Hb) Louisville

A Predictive Statistical Model To Identify Thalassemic Phenotype (β 0 vs β + ) in Heterozygous β-Thalassemia.

Serum Soluble Transferrin Receptor in Heterozygous β-Thalassaemia: Application in the Diagnosis of Iron Deficiency and as Hematologic Marker of Erythroid Activity According to Thalassaemic Genotypes (β 0 vs β + ).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only